Visiomed Group was one of the Paris market's biggest gainers on Tuesday, after reporting "record" results for the 2023 financial year, a performance which it believes confirms the existence of a "new dynamic".

For the first time in its stock market history, the connected health specialist said it had generated "tangible" and "recurring" sales and operating profit.

Smart Salem, its network of digital medical analysis centers in the Middle East, saw its sales climb by 38% to 13.7 million euros last year.

Operating income before non-recurring items (Ebitda) reached a record level of 3.5 million euros on a normalized basis and 2.2 million euros on a consolidated basis, resulting in a positive net profit of 1.1 million euros.

Visiomed also reports an increase in gross cash and a "controlled" net debt of five million euros, while highlighting a 2024 outlook in line with its "very positive" trajectory.

The Group says it is confident in its ability to sustain growth and profitability in 2024, thanks to the performance of Smart Salem, ongoing control of structural costs and the acceleration of its project in Saudi Arabia.

On the Paris Bourse, Visiomed shares were up by more than 7% on Tuesday morning following all these announcements. The stock is still down 18% since the start of the year.

Copyright (c) 2024 CercleFinance.com. All rights reserved.